FEATURES OF CLINICAL AND HORMONAL PARAMETERS AT WOMEN WITH REGULAR MENSTRUAL CYCLES AND POLYCYSTIC OVARIES

Authors

DOI:

https://doi.org/10.21856/j-PEP.2013.3.08

Keywords:

polycystic ovaries syndrome, ultrasound diagnostic, anti-mullerian hormone

Abstract

It was a comparative analysis of clinical and hormonal parameters in women with normal
menstrual cycles and cystic degenerate ovaries, polycystic ovary syndrome (PCOS) patients and
healthy women. There were no significant differences in the content of testosterone, estradiol,
dehydroepiandrosterone sulfate, 17-OH progesterone, prolactin and sex hormone binding globulin
in the blood serum of healthy women and women with cystic degenerate ovaries. Indicators of antimullerian hormone in patients with cystic degenerate ovaries were significantly higher than in healthy,
but lower than in patients with PCOS. As with PCOS levels of anti-mullerian hormone in women with
ovarian degenerate cystic positively correlated with ovarian volume, the number of antral follicles and
the level of luteinizing hormone. It is suggested that cystic degenerate ovaries are not normal, but
rather — a milder phenotype of PCOS.

References

Guriev TD. Akusherstvo, Ginekologija i Reprodukcija 2010; 4(2):10–15|.

Norman RJ, Dewailly D, Legro RS, et al. J Obstet Gynaecol Can 2008; 30(8):671–679.

Dunaif A, Given JR, Haseltine FP. Diagnostic criteria for Polycystic ovary syndrome: towards a rational apporoach. In polycystic ovary syndrome, Boston, 1992:377–384.

The Rotterdam ESHRE/ASRM- sponsored PCOS consensus workshop group. Hum Reprod 2004; 19(1):41–47.

Porter MB. Semin Reprod Med 2008; 26(3):241–251.

Kristensen SL, Ramlau-Hansen CH, Ernst E, et al. Hum Reprod 2010; 25(12):3117–3122.

Updata in Bariatic Endocrinology 2013; 3–4, available at: http://endocrineweb.com/professional/en.

Duijkers IJ, Klipping C. Gynecol Endocrinol 2010; 26:152–160.

Suba Mujeeb, Imrana Masroor, Nida Najmi. Pakistan J Radiol 2008; 18(1):5–8.

Balen A, Selaven I, Tan S, et al. Hum Reprod 2003; 9(6):505–514.

Mortensen M, Rosenfield RL, Littlejohn E. J Clin Endocrinol 2006; 91(6):3786–3790.

Dedov II. Sindrom polikistoznyh jaichnikov: rukovodstvo dlja vrachej, Moskva, 2007:368 p.

Lujan ME, Jarrett BY, Brooks ED, et al. Hum Reprod 2013; 28(5):1361–1368.

Ferriman D, Gallwey J. J Clin Endocrinol Metabol 1961; 21:1440–1447.

Manuhin IB, Gevorkjan MA, Chagaj N B. Anovuljacija i insulinorezistentnost’, Moskva, 2006:416 p.

Piouka A, Farmakiotis D, Katsikis I, et al. J Physiol Endocrinol Metabol 2009; 296(2):238–243.

Adams JM, Taylor AE, Crowley JhWF, Hall JE. J Clin Endocrinol 2004; 89(9):4343–4350.

Christine M, Solorzano Burt, Beller JP, et al. Steroid 2012; 77(4):332–337.

Eilertsen T, Vanky E, Carlsen S. Hum Reprod 2012; 27(18):2494–2502.

Parco S, Novelli C, Vascotto F, et al. Int J Gen Med 2011; 4(2):759–763.

Anderson RA, Nelson SM, Wallace WH. Maturitas 2012; 71(1):28–33.

Homburg R, Ray A, Bhide P, et al. Reprod Hum 2013; 28(4):1077–103.

Pellatt L, Hanna L, Brincat M, et al. J Clin Endocrinol Metabol 2007; 92(1):240–245.

Cattean-Jonard S, Bancquart J, Poncelet E, et al. Ultrasound Obstet Gynecol 2012; 40(2):223–229.

Downloads

Published

2013-10-10

How to Cite

Arkhypkina, T. (2013). FEATURES OF CLINICAL AND HORMONAL PARAMETERS AT WOMEN WITH REGULAR MENSTRUAL CYCLES AND POLYCYSTIC OVARIES. Problems of Endocrine Pathology, 45(3), 63-69. https://doi.org/10.21856/j-PEP.2013.3.08

Issue

Section

CLINICAL ENDOCRINOLOGY